Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript February 26, 2026 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.14 ...
Expect lines at these Pennsylvania buffet spots, where fresh dishes and endless options make every minute worth it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results